Quick Answer
ZIMMER BIOMET HOLDINGS, INC. reported R&D Expense of $225.60 million for fiscal year 2012.
ZIMMER BIOMET HOLDINGS, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2012 | $225.60M | -5.4% |
| 2011 | $238.40M | +9.1% |
| 2010 | $218.50M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| March 31, 2013 | $53.50M | -10.2% | +0.0% |
| September 30, 2012 | $53.50M | -12.3% | -10.2% |
| March 31, 2012 | $59.60M | — | -2.3% |
| September 30, 2011 | $61.00M | — | — |
- ZIMMER BIOMET HOLDINGS, INC. showed a decrease of -5.4% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2012 period, ZIMMER BIOMET HOLDINGS, INC.’s r&d expense has grown by 3.2% (from $218.50 million to $225.60 million).
- The most recent figure is from ZIMMER BIOMET HOLDINGS, INC.’s fiscal year 2012 report (Form 10-K), filed with the SEC on February 27, 2013.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: